CAY10471 Racemate is the racemic form of a potent and selective antagonist of the prostaglandin E2 (PGE2) EP4 receptor. It is primarily utilized in research settings to study its effects on PGE2-mediated biological pathways, particularly in inflammation, pain, and immune response modulation. As a tool compound in pharmacological studies, it helps investigate the role of the EP4 receptor in cellular processes. Researchers use it to explore potential therapeutic applications in conditions involving excessive PGE2 signaling, such as inflammatory diseases, cancer progression, and certain neurological disorders. The racemic form enables examination of both enantiomers' activity and selectivity, providing insights into stereochemistry's impact on biological activity. Additionally, it serves as a reference material in the development of more targeted and potent EP4 antagonists for potential drug candidates.